PD-L1 expression is associated with epithelial-mesenchymal transition in head and neck squamous cell carcinoma.
about
Clinicopathologic implications of immune classification by PD-L1 expression and CD8-positive tumor-infiltrating lymphocytes in stage II and III gastric cancer patients.Prognostic value of programmed cell death ligand 1 expression in patients with head and neck cancer: A systematic review and meta-analysis.Programmed death-ligand 1 expression at tumor invasive front is associated with epithelial-mesenchymal transition and poor prognosis in esophageal squamous cell carcinoma.New insights into the role of EMT in tumor immune escape.Prognostic impact of immune microenvironment in laryngeal and pharyngeal squamous cell carcinoma: Immune cell subtypes, immuno-suppressive pathways and clinicopathologic characteristics.PD-L1 expression correlates with VEGF and microvessel density in patients with uniformly treated classical Hodgkin lymphoma.STAT3-targeted treatment with silibinin overcomes the acquired resistance to crizotinib in ALK-rearranged lung cancer.Integrative Analysis Identifies a Novel AXL-PI3 Kinase-PD-L1 Signaling Axis Associated with Radiation Resistance in Head and Neck Cancer.Relationship of Metabolic Alterations and PD-L1 Expression in Cisplatin Resistant Lung Cancer.Immunotherapy of WAP-TNP mice with early stage mammary gland tumors.Type Iγ phosphatidylinositol phosphate kinase regulates PD-L1 expression by activating NF-κB.Increased PD-L1 expression in erlotinib-resistant NSCLC cells with MET gene amplification is reversed upon MET-TKI treatment.Changes in programmed death-ligand 1 expression during cisplatin treatment in patients with head and neck squamous cell carcinoma.Melanoma subtypes demonstrate distinct PD-L1 expression profiles.A novel bifunctional anti-PD-L1/TGF-β Trap fusion protein (M7824) efficiently reverts mesenchymalization of human lung cancer cells.Crk adaptor protein promotes PD-L1 expression, EMT and immune evasion in a murine model of triple-negative breast cancer.miR-34a attenuates glioma cells progression and chemoresistance via targeting PD-L1.Prospects for new lung cancer treatments that target EMT signaling.The role of STAT3 in leading the crosstalk between human cancers and the immune system.Matrix stiffness and tumor-associated macrophages modulate epithelial to mesenchymal transition of human adenocarcinoma cells.ATM‑JAK‑PD‑L1 signaling pathway inhibition decreases EMT and metastasis of androgen‑independent prostate cancer.Epithelial-mesenchymal transition-converted tumor cells can induce T-cell apoptosis through upregulation of programmed death ligand 1 expression in esophageal squamous cell carcinoma.Prognostic impact of programmed cell death ligand 1 (PD-L1) expression and its association with epithelial-mesenchymal transition in extrahepatic cholangiocarcinoma.Chemotherapeutic Treatments Increase PD-L1 Expression in Esophageal Squamous Cell Carcinoma through EGFR/ERK ActivationRelationship between epithelial-to-mesenchymal transition and the inflammatory microenvironment of hepatocellular carcinoma
P2860
Q33688662-3606A334-6EC8-4A3A-8500-CBE57A738E44Q33788235-3720D7BF-2EE3-4878-A6B1-845CBE33AC8DQ33823290-074176F3-15D9-4472-BEF5-1927BAE2CA3BQ33869781-8CDC3340-07AD-4E7D-8A32-4671FE7718A6Q37745995-052BB64E-69ED-4FC8-9954-56CC04499150Q38607549-1BDBD404-4D4F-4289-BF3B-F134E5231FCBQ38740295-BC44FA57-38BA-45CC-A066-42053DD96970Q38801345-F3D0EACF-A111-442A-95B9-57193E1F5CB7Q41409074-E7A6599F-0CA9-4F2F-A468-A2D2BAA7F80BQ41924363-F0F7C9EB-A104-4F41-950B-4062A0CF7A3FQ41964740-05CF6638-FCBA-45DF-9393-DAE3D2861A1AQ41998799-7198D5FA-91B0-45ED-949A-485711A85DB2Q47095674-72F8691D-19BA-4ABC-B549-12BD23EDE290Q47107364-1ABC44DD-1DE4-46F0-B05A-F56287143557Q47155204-525460B2-DF6E-4C5C-ABE5-D9F91B645060Q47217165-AFF7896B-C3AF-4CAB-9C74-A7ECF565B179Q48189611-2BFAABC8-227D-494D-B502-F8F83E8D5764Q48271468-74445F13-BCF7-4246-82A9-DCE8CAF13A63Q49990319-FED7E6A9-CA24-4259-9861-5D7D0AADC5B4Q52338220-05ADBB52-1ED2-48A1-8CD8-8F3772DD7BBBQ52641296-8E0ABD5D-C85E-4C80-B894-622D3183C719Q54977452-AB598D71-0B02-46E9-BDCC-D840BCF386B4Q55262931-0785CFD1-77AB-4E22-A722-705D6D4C56F1Q56761471-FD755D92-BBC7-49FA-9738-CE8140A89197Q58696594-8A36B8BA-C7E7-4EF2-9EC5-BEC5F3AC3CFF
P2860
PD-L1 expression is associated with epithelial-mesenchymal transition in head and neck squamous cell carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 February 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
PD-L1 expression is associated ...... neck squamous cell carcinoma.
@en
PD-L1 expression is associated ...... neck squamous cell carcinoma.
@nl
type
label
PD-L1 expression is associated ...... neck squamous cell carcinoma.
@en
PD-L1 expression is associated ...... neck squamous cell carcinoma.
@nl
prefLabel
PD-L1 expression is associated ...... neck squamous cell carcinoma.
@en
PD-L1 expression is associated ...... neck squamous cell carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
PD-L1 expression is associated ...... neck squamous cell carcinoma.
@en
P2093
Bhumsuk Keam
Chan-Young Ock
Dae Seog Heo
Dong-Wan Kim
Hong-Gyun Wu
Jin-Ho Kim
Ju-Seog Lee
Myung-Whun Sung
P2860
P304
15901-15914
P356
10.18632/ONCOTARGET.7431
P407
P577
2016-02-17T00:00:00Z